Online citations, reference lists, and bibliographies.
← Back to Search

Intracystic Therapies For Cystic Craniopharyngioma In Childhood

U. Bartels, N. Laperriere, E. Bouffet, J. Drake
Published 2012 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Introduction: Craniopharyngioma of childhood are commonly cystic in nature. An intracystic catheter insertion and subsequent instillation of substances inducing cyst shrinkage seems a beneficial strategy avoiding additional morbidity in a highly vulnerable brain location. Methods: A systematic review of the medical literature was performed to identify potentially relevant, all languages articles using Ovid MEDLINE and EMBASE from inception to July 2011 and Cochrane Central Register of Controlled Trials to third quarter 2011. All references were examined for relevancy. Results: Of 142 unique references, 71 referred to substances used for intracystic craniopharyngioma treatment. General aspects of intracystic catheter insertion as well as response rates, risks, and outcomes of children treated with intracystic radioisotopes, bleomycin, and interferon (IFN) are critically reviewed and an outline for potential future endeavors provided. Conclusion: IFN seems currently the intracystic substance with the best benefit risk ratio. The authors advocate for consensus on prospective data collection and standardized intracystic treatment strategies to allow reliable comparisons and herewith optimize treatment and outcome.
This paper references
[Stereotaxic treatment of expanding cysts in craniopharyngiomas by endocavitary beta-irradiation (Re-186; Au-198; Y-90)].
A. Musolino (1985)
10.1097/00006123-199702000-00006
Cystic craniopharyngioma: long-term results after intracavitary irradiation with stereotactically applied colloidal beta-emitting radioactive sources.
J. Voges (1997)
10.1002/cncr.22633
Intracystic bleomycin therapy for craniopharyngioma in children
J. Hukin (2007)
WHO classification of tumours of the central nervous system
D. N. Louis (2007)
Longterm results and late complications after intracavitary yttrium-90
J. Julow (2007)
10.1016/j.clineuro.2006.09.002
Radiological findings following postsurgical intratumoral bleomycin injection for cystic craniopharyngioma
Sang-Dae Kim (2007)
10.3171/PED-07/10/318
Neuroradiological findings of bleomycin leakage in cystic craniopharyngioma. Report of three cases.
L. Lafay-Cousin (2007)
10.3171/2009.9.JNS09301
Recurrence rates after neuroendoscopic fenestration and Gamma Knife surgery in comparison with subtotal resection and Gamma Knife surgery for the treatment of cystic craniopharyngiomas.
Young Seok Park (2011)
10.1007/s00381-001-0524-5
Intracystic chemotherapy with bleomycin in the treatment of craniopharyngiomas
C. Mottolese (2001)
10.1016/S1130-1473(02)70576-9
Intratumoural bleomycin as a treatment for recurrent cystic craniopharyngioma. Case report and review of the literature.
J. Alen (2002)
10.1007/s00381-005-1220-7
Childhood craniopharyngioma: Vancouver experience
J. Hukin (2005)
Medical errors. Dosage nomenclature of bleomycin needs to be standardised to avoid errors.
A. Stefanou (2001)
10.3171/JNS.1990.73.4.0534
Craniopharyngiomas in children. Long-term effects of conservative surgical procedures combined with radiation therapy.
E. G. Fischer (1990)
10.1007/s00381-005-1208-3
Long-term outcome and reconsideration of intracystic chemotherapy with bleomycin for craniopharyngioma in children
H. Takahashi (2005)
10.3346/JKMS.2002.17.2.254
Outcome of postoperative intratumoral bleomycin injection for cystic craniopharyngioma.
D. H. Park (2002)
10.3171/JNS.1961.18.2.0217
Craniopharyngiomas. Treatment by combined surgery and radiation therapy.
S. Kramer (1961)
10.1016/0360-3016(95)00175-X
Phosphorus-32 intracavitary irradiation of cystic craniopharyngiomas: current technique and long-term results.
B. Pollock (1995)
Colloidal radioisotopes as part of a multi-modality treatment of craniopharyngiomas.
Backlund Eo (1989)
10.1080/02688699943457
Stereotactic intracavitary therapy of recurrent cystic craniopharyngioma by instillation of 90yttrium.
T. Blackburn (1999)
10.3171/PED.2007.106.5.391
Delayed neurotoxic complication of intracavitary bleomycin therapy for craniopharyngioma in a child who had previously undergone radiosurgery. Case report.
D. Belen (2007)
Intracystic bleomycin therapy for craniopharyngioma
J. Hukin (2007)
Does chemotherapy have a role in the management of craniopharyngioma?
D. Hargrave (2006)
[Intracystic therapy of bleomycin for craniopharyngioma--effect of bleomycin for cultured craniopharyngioma cells and intracystic concentration of bleomycin (author's transl)].
O. Kubo (1974)
The classification of tumours of the central nervous system.
R. O. Barnard (1982)
10.1007/s00381-005-1227-0
Intracavitary therapeutic options in the management of cystic craniopharyngioma
A. Cáceres (2005)
10.1177/088307380301801201
Randomized Treatment Study of Inosiplex Versus Combined Inosiplex and Intraventricular Interferon-α in Subacute Sclerosing Panencephalitis (SSPE): International Multicenter Study
G. Gascon (2003)
10.1016/j.surneu.2007.05.048
Does the choice of surgical approach to insert an intratumoral catheter influence the results of intratumoral cystic treatment?
N. Zanon (2008)
Uso de la bleomicina mediante un reservorio local en pacientes con craneofaringiomas quísticos
J. Hernandez (2002)
10.1007/s00381-002-0638-4
Neuroendoscopic placement of Ommaya reservoir into a cystic craniopharyngioma
T. Joki (2002)
Intratumoral bleomycin injection as a primary therapy for cystic cranio
S. H. Yang (2009)
10.1007/s00381-010-1245-4
The role of inflammation in the genesis of the cystic component of craniopharyngiomas
B. Pettorini (2010)
Long-term outcome and reconsideration of intracystic chemotherapy with bleomycin for craniopharyngioma
H. Takahashi (2005)
Apoptosis in alpha interferon
D. F. Ierardi (2007)
Y-90)
10.1055/s-0029-1225617
Endoscopic, image-guided, transnasal instillation of (32)P for recurrent infrachiasmatic cystic craniopharyngioma.
John R. Floyd (2009)
Apoptosis in alpha interferon (IFN-alpha) intratumoral chemotherapy for cystic craniopharyngiomas.
D. Ierardi (2007)
Stereotaxic treatment of expanding cysts
A. Musolino (1985)
10.1007/s00381-005-1242-1
Craniopharyngiomas: our experience in Lyon
C. Mottolese (2005)
10.1227/01.NEU.0000335786.10968.2F
MANAGEMENT OF CYSTIC CRANIOPHARYNGIOMAS WITH STEREOTACTIC ENDOCAVITARY IRRADIATION USING COLLOIDAL 186: A RETROSPECTIVE STUDY OF 48 CONSECUTIVE PATIENTS
S. Derrey (2008)
Studies on craniopharyngiomas. 3. Stereotaxic treatment with intracystic yttrium-90.
E. Backlund (1973)
Use of bleomycin through a local reservoir in patients
J. Hernandez (2002)
10.1016/j.radonc.2010.12.001
Phosphorus-32 therapy for cystic craniopharyngiomas.
R. Barriger (2011)
Consensus and perspectives on treatment strategies in childhood craniopharyngioma: results of a meeting of the Craniopharyngioma Study Group (SIOP), Genova, 2004.
H. Müller (2006)
10.1159/000103306
Craniopharyngiomas in Children
Kazumi Ohmori (2007)
Stereotaxic treatment of expanding cysts in craniopharyngiomas by endocavitary betairradiation
A Musolino (1985)
Expres - sion analysis of hialuronic acid sintases and hyaluronidases in craniopharyngiomas tissue and quantification of hyaluronic acid in intratumoral liquid during alpha interferon chemotherapy
D. Ierardi (2009)
10.3171/2010.1.FOCUS09315
Intracystic treatments for craniopharyngioma.
P. Steinbok (2010)
10.1007/s00381-005-1185-6
Individualized treatment of pediatric craniopharyngiomas
A. Albright (2005)
10.1227/01.NEU.0000255528.68963.EF
LONG‐TERM RESULTS AND LATE COMPLICATIONS AFTER INTRACAVITARY YTTRIUM‐90 COLLOID IRRADIATION OF RECURRENT CYSTIC CRANIOPHARYNGIOMAS
Jenö Julow (2007)
10.1016/j.ijrobp.2004.12.071
Dose distribution outside of a sphere of P-32 chromic phosphorous colloid.
Charles D Hechtman (2005)
Phase II evaluation of interferon-alpha-2a for progressive or recurrent craniopharyngiomas.
R. Jakacki (2000)
10.1159/000120860
Craniopharyngioma: results of survey of the American Society of Pediatric Neurosurgery.
R. Sanford (1994)
10.1038/nrendo.2010.168
Childhood craniopharyngioma—current concepts in diagnosis, therapy and follow-up
H. Müller (2010)
10.3171/JNS.1996.84.1.0124
Use of bleomycin in intratumoral chemotherapy for cystic craniopharyngioma. Case report.
S. Cavalheiro (1996)
Neuro - radiological findings of bleomycin leakage in cystic craniopharyngioma . Report of three cases
L. Lafay-Cousin (2007)
10.1227/01.NEU.0000114262.30035.AF
Management of Cystic Craniopharyngiomas with Phosphorus-32 Intracavitary Irradiation
T. Hasegawa (2004)
Consensus and perspectives
H. L. Müller (2006)
10.1016/J.APRADISO.2007.01.018
Dosimetry of (32)P radiocolloid for treatment of cystic craniopharyngioma.
M. Sadeghi (2007)
10.3171/ped.2006.104.2.5
Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function.
T. Merchant (2006)
Random - ized treatment study of inosiplex versus combined inosiplex and intraventricular interferonalpha in subacute sclerosing panencephalitis ( SSPE ) : international multicenter study
G. G. Gascon (2003)
Intratumoral bleomycin injection as a primary therapy for cystic craniopharyngioma
S. H. Yang (2009)
Craniopharyn - giomas . Treatment by combined surgery and radiation therapy
S. Kramer (1961)
10.1007/978-3-7091-9419-5_13
Stereotactic endoscopic interventions in cystic brain lesions.
D. Hellwig (1995)
10.3171/2009.4.PEDS0978
Endoscopic transventricular positioning of intracystic catheter for treatment of craniopharyngioma. Technical note.
B. Pettorini (2009)
Phase II trial of conformal radiation therapy for pedi
T. E. Merchant (2006)
J. Neurosurg
10.1136/bmj.1.5803.764
Craniopharyngiomas.
H. J. Hoffman (1950)
10.1159/000061227
The role of radiotherapy in the treatment of craniopharyngioma--indications, results, side effects.
G. Becker (1999)
10.1093/NEUROSURGERY/46.1.213
Fatal toxic effect of bleomycin on brain tissue after intracystic chemotherapy for a craniopharyngioma: case report.
A. Savaş (2000)
10.3109/02688699409101192
Toxic effects of bleomycin on the hypothalamus following its administration into a cystic craniopharyngioma.
T. Haisa (1994)
10.1159/000055955
Intratumoral Therapy with Bleomycin for Cystic Craniopharyngiomas in Children
W. Hader (2000)
10.1159/000068014
Preliminary Exploration of the Clinical Effect of Bleomycin on Craniopharyngiomas
R. Jiang (2002)
Colloidal radioisotopes as part of a multi-modality treatment of craniopharyngiomas.
E. Backlund (1989)
Delayed neurotoxic
H. Bolay (2007)
10.1097/CAD.0b013e328325465e
Bleomycin treatment of brain tumors: an evaluation.
Mette Linnert (2009)
Expression analysis of hialuronic acid sintases and hyaluronidases in craniopharyngiomas tissue and quantification of hyaluronic acid in intratumoral liquid during alpha interferon chemotherapy
D Ierardi (2009)
Radiological findings following postsurgical intratumoral
Kim (2007)
Expression analysis of hialuronic acid
D. Ierardi (2009)
10.1182/asheducation-2005.1.503
Medical errors.
A. R. Holder (2005)
La somministrazione di Bleomicina intracavitaria nel trattamento chirurgico del craniofaringioma cistico
A. Franzini (2001)
10.1007/s007010050341
Intracavitary Chemotherapy of Polycystic Craniopharyngioma with Bleomycin
A. Savaş (1999)
10.1007/s00381-005-1226-1
Use of interferon alpha in intratumoral chemotherapy for cystic craniopharyngioma
S. Cavalheiro (2005)
10.3171/2010.1.FOCUS09310
Craniopharyngiomas: intratumoral chemotherapy with interferon-alpha: a multicenter preliminary study with 60 cases.
S. Cavalheiro (2010)
10.3171/JNS.1985.62.1.0120
Evaluation of postoperative intratumoral injection of bleomycin for craniopharyngioma in children.
H. Takahashi (1985)



This paper is referenced by
10.3171/2016.1.JNS152238
Endonasal endoscopic reoperation for residual or recurrent craniopharyngiomas.
S. Dhandapani (2017)
10.1007/978-3-030-41176-3
Adult Craniopharyngiomas: Differences and Lessons from Paediatrics
Emmanuel Jouanneau (2020)
10.1093/neuonc/nox056
Intracystic interferon-alpha in pediatric craniopharyngioma patients: an international multicenter assessment on behalf of SIOPE and ISPN
J. Kilday (2017)
10.3171/2015.2.PEDS14656
Intracystic interferon-α treatment leads to neurotoxicity in craniopharyngioma: case report.
Julia D Sharma (2015)
10.1016/j.clineuro.2018.01.039
Craniopharyngiomas: A systematic review and evaluation of the current intratumoral treatment landscape
Oliver D Mrowczynski (2018)
10.1155/2016/3601395
Intracavitary Irradiation as a Safe Alternative for Cystic Craniopharyngiomas: Case Report and Review of the Literature
Alejandro Enriquez-Marulanda (2016)
10.1038/nrendo.2016.217
New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma
H. Müller (2017)
10.1007/978-3-662-48700-6_41
Kraniopharyngeome bei Kindern
Herbert Müller (2018)
10.1007/s00066-015-0910-7
Stereotactic intracavitary brachytherapy with P-32 for cystic craniopharyngiomas in children
M. Maarouf (2015)
10.3171/2013.3.JNS122214
Molecular oncogenesis of craniopharyngioma: current and future strategies for the development of targeted therapies.
I. Hussain (2013)
10.1007/978-3-319-51890-9_1
Pathogenesis of Human ACP
A. Hoelsken (2017)
10.1016/B978-0-12-416706-3.00027-1
Craniopharyngioma – Pediatric Management
Hermann L. Müller (2015)
10.1007/978-3-319-51890-9_9
Intracystic Administration of Interferon-Alpha for Reduction of Cystic Tumour Burden
J. Kilday (2017)
10.1007/978-3-030-11339-1_3
Adamantinomatous Craniopharyngioma: Genomics, Radiologic Findings, Clinical, and Prognosis
H. Müller (2019)
10.1002/14651858.CD008890.pub4
Intracystic bleomycin for cystic craniopharyngiomas in children.
Si Zhang (2016)
10.1007/978-3-319-51890-9_10
Long-Term Management and Clinical Trials in Adamantinomatous Craniopharyngioma
Hermann L. Müller (2017)
10.1016/B978-0-12-416706-3.00028-3
Surgery of Craniopharyngiomas in Children
James A. Balogun (2015)
10.3171/2019.8.PEDS19336
A novel management proposal for intrinsic brainstem neurenteric cysts: case report.
G. Agresta (2019)
10.1093/neuonc/not026
Trends in treatment and outcomes of pediatric craniopharyngioma, 1975-2011.
M. Cohen (2013)
10.3389/fendo.2012.00080
Craniopharyngioma – A Childhood and Adult Disease with Challenging Characteristics
H. Müller (2012)
10.3171/2017.7.PEDS17295
Suprasellar and recurrent pediatric craniopharyngiomas: expanding indications for the extended endoscopic transsphenoidal approach.
A. Alalade (2018)
10.1016/B978-0-12-802395-2.00033-X
Bioimaging and surgery of brain tumors.
Georg Widhalm (2017)
10.1007/978-3-319-31889-9_55-1
Hydrocephalus Caused by Basal Ganglia, Thalamic, and Suprasellar Tumors
Jonathan Roth (2018)
10.1007/s00381-019-04480-x
Outcome of Chinese children with craniopharyngioma: a 20-year population-based study by the Hong Kong Pediatric Hematology/Oncology Study Group
Anthony P Y Liu (2020)
10.5348/IJCRI-2013-12-419-CR-13
Unexpected brain atrophy following administration of intratumoral interferon alpha-2b for cystic craniopharyngioma: A case report
Khadiga Elfadil Ahmed Mohammed (2014)
The Changing Face of Craniopharyngioma Treatment in Young Children and its Challenges at a Single Centre in a Developing World Context
Ncedile Mankahla (2019)
10.1093/neuonc/nox147
Intracystic interferon-alpha in pediatric craniopharyngioma patients-reply.
K. Johnpaul (2017)
10.1007/s00381-020-04677-5
Adamantinomatous craniopharyngioma in the molecular age and the potential of targeted therapies: a review
Ros Whelan (2020)
10.1002/pbc.25889
A Cross‐Sectional Cohort Study of Cerebrovascular Disease and Late Effects After Radiation Therapy for Craniopharyngioma
A. Lo (2016)
10.1007/978-3-030-04152-6_30
Craniopharyngioma: Current Classification, Management, and Future Directions
Z. Habibi (2019)
10.22037/IJCN.V11I3.11666
Treatment of Cystic Craniopharyngioma with Intracystic Stereotactic Instillation of Phosphorus 32
Sohrab Shahzadi (2017)
10.1007/s00381-012-1926-2
A systematic review of the results of surgery and radiotherapy on tumor control for pediatric craniopharyngioma
A. Clark (2012)
See more
Semantic Scholar Logo Some data provided by SemanticScholar